| NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study (NCT02692157) | New York State Psychiatric Institute | 2016-02-01 |
| Evaluation of Intranasal Naltrexone and Naloxone (NCT03851731) | National Institute on Drug Abuse (NIDA) | 2015-10-05 |
| Medication-Assisted Treatment for Youth With Substance Use Disorders (NCT02593474) | New York State Psychiatric Institute | 2015-09-01 |
| Expanded HIV Care in Opioid Substitution Treatment (EHOST) Trial (NCT02440256) | Simon Fraser University | 2015-09-01 |
| Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder (NCT02559973) | Indivior Inc. | 2015-09-01 |
| Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension) (NCT02537574) | Alkermes, Inc. | 2015-08-01 |
| An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery (NCT03604861) | Indivior Inc. | 2015-08-01 |
| Opiate Craving Reduction Study Using Post-detox Patients on Suboxone and Use of TEAS as Adjunctive Treatment (NCT02033746) | Mclean Hospital | 2015-08-01 |
| Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder (NCT02510014) | Indivior Inc. | 2015-07-27 |
| Phase II Pharmacokinetics Study of CAM2038 (NCT02710526) | Braeburn Pharmaceuticals | 2015-02-01 |
| Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and Treatment (NCT06249542) | Kaiser Permanente | 2015-01-01 |
| A Randomized Trial of Interim Methadone and Patient Navigation Initiated in Jail (NCT02334215) | Friends Research Institute, Inc. | 2014-12-15 |
| Cocaine Opioid Oxytocin Option - Limited (NCT02028533) | University of California, San Francisco | 2014-07-01 |
| Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (NCT01908062) | Oregon Health and Science University | 2014-06-01 |
| Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program (NCT02120612) | Edward Hospital | 2014-04-01 |
| Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (NCT02032433) | NYU Langone Health | 2014-01-29 |
| Medication-assisted Treatment for Injecting Drug Users in Vietnam (NCT05368675) | University of Pennsylvania | 2013-12-18 |
| Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder (NCT02044094) | Indivior Inc. | 2013-11-01 |
| RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure (NCT02334111) | Boston Medical Center | 2013-07-01 |
| Buprenorphine in the Emergency Department (NCT03174067) | St. Joseph's Health Centre Toronto | 2013-03-01 |
| Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients (NCT01841931) | Theresa Jacob, PhD, MPH | 2013-02-01 |
| Substance Use and Lifestyle-related Health Problems in Ageing Patients in OMT Treatment (NCT05182918) | Sorlandet Hospital HF | 2012-12-01 |
| Single Ascending Dose Study of RBP-6000 (NCT03002961) | Indivior Inc. | 2012-07-01 |
| Single-dose, Study of RBP-6000 in Opioid Dependent Individuals (NCT02765867) | Indivior Inc. | 2010-11-01 |
| Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning (NCT01730781) | Yale University | 2010-07-01 |